Sumitomo Pharma announces availability of ORGOVYX in Canada

The first and only oral androgen deprivation therapy treatment for men with advanced prostate cancer

Indranil Sen, CFO, Biocon resigned

Sen spent a decade with Biocon and held various key roles,

Zydus launches generic version of Olaparib ‘IBYRA’ in India

The drug will target specific genetic mutations prevalent in certain types of cancers

Cureskin secures US$ 20 million in Series B funding

Cureskin aims to disrupt the large and growing skin and hair care industry in India

Dr Mandaviya launches Credit Assistance Program for Jan Aushadhi Kendras

From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today

Govt. announces the revamped pharmaceuticals technology upgradation assistance scheme

Merck completes acquisition of Harpoon Therapeutics

Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 (MK-6070), an investigational delta-like ligand 3 (DLL3) targeting T-cell engager

USFDA grants Orphan Drug Designation for iOnctura's first-in-class autotaxin cancer therapy

It is the first autotaxin inhibitor to be investigated in cancer patients

Pfizer announces positive Phase 3 trial of ADCETRIS regimen in patients with DLBCL

Pfizer to discuss regulatory submission with FDA, potentially leading to eighth indication for ADCETRIS

North India’s first government homoeopathic college coming up in Kathua: Dr. Jitendra Singh

The institution will be spread over an area of more than 8 acres